• PIK3CA Gene Mutation Analysis (Therascreen PIK3CA)
  • Blastomyces Antigen, Quantitative, Bronchoalveolar Lavage
  • 11-Dehydro-Thromboxane B2, Urine
  • Beta Thalassemia Genetic Testing
  • Hemoptysis
  • Culture, Uterine
  • Polyoma BK Virus, PCR, Quantitative, Urine
  • Cyclin-D1 (BCL1) Expression, Immunohistochemistry, Tissue
  • Adenovirus Antibody
  • G-protein gated Inwardly Rectifying K+ channel 4 (GIRK4) Genotyping
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Specimen Collection
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.